World Courier expands fleet as EU GDP rules drive demand for compliance

By Dan Stanton

- Last updated on GMT

Related tags: European union

World Courier expands fleet as EU GDP rules drive demand
World Courier says it is expanding its European ground fleet as pharma and supplier demand grows in the wake of new EU GDP guidelines.

The guidelines on Good Distribution Practice of Medicinal Products for Human Use which came into effect last November​ require evidence of temperature controlled handling and storage for pharmaceuticals.

In order to deal with an increase in demand, pharma logistic company World Courier is upgrading its groundforce to deal with an additional 27 Sprinters and four 13.8 metre trailers.

“It is no longer acceptable to assume that refrigerated trucks or ambient trucks will supply an adequate environment for shipping,”​ spokesperson Sue Lee told

“The new vehicles are needed because of expanding demand by pharma companies and suppliers to be able to prove that all label requirements for pharmaceutical supplies have been met.”

Lee added all current vehicles in the fleet are already compliant with the new requirements, which were drafted in March last year, but have been further fitted with enhanced security measures designed to improve road and vehicle safety.

“Clients are very anxious for the new capacity to come on line as soon as the qualification has been completed at Controlled Room Temperature (CRT),”​ she continued. “Currently our lead time for a shipment can be as much as a week at times of high demand.”

However, the increased fleet size will improve response time, she added, “as more vehicles will be based on main land Europe and availability for shipping.”


News of the extended fleet comes just a month after the firm announced it was in the final stages of creating a new facility in Wales, UK, to support local clients looking to ship biological samples, medical devices and spare parts.

World Courier UK Manager Simon Beaumont said: “The brand new 250 square metre facility will offer significant benefits, to our growing customer base in South Wales, including locally based drivers and industry leading packaging systems, along with GDP compliant, mapped, calibrated and monitored cold chain capacity, with redundant systems in place.”

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more